Competition

Competition — Partners Group Holding AG (PGHN)

Figures converted from CHF at historical FX rates — see data/company.json.fx_rates. Ratios, margins, and multiples are unitless and unchanged.

Competitive Bottom Line

Partners Group has a real but narrow moat built on bespoke client architecture rather than scale. Inside its niche — institutional separate accounts and pioneered evergreen private-markets products that together account for 67% of AuM — it earns the highest EBITDA margin (62.8%) and the highest ROE (55%) in the listed alternative-asset peer group, well ahead of Blackstone (50%), EQT (52%), Apollo (26%) and Ares (20%). Outside that niche it is sub-scale: at USD 184.9bn AuM, PGHN is one-seventh the size of Blackstone and one-fifth of Apollo, and it has no insurance balance sheet to recycle permanent capital the way KKR's Global Atlantic and Apollo's Athene do. The single competitor that matters most is Blackstone — not as a buyout rival but as the firm whose private-wealth distribution machine (BREIT, BCRED, BXPE) sets the velocity benchmark for the evergreen channel that drove PGHN's 2024-25 inflows. If BX continues to capture that channel at multiples of PGHN's pace, the bespoke-margin advantage erodes through mix shift before any single client is lost.

The Right Peer Set

The five public alternative-asset managers below are direct economic substitutes: each runs a fee-related-earnings + carried-interest model on third-party private-markets capital, and each competes for the same institutional and private-wealth pools as PGHN. The Dan-staged peer set excluded Brookfield (real-asset-heavy, spinoff comp complexity), Carlyle (volatile carry pattern), and the smaller European peers Bridgepoint and 3i (sub-scale or balance-sheet-investing model). Inside the chosen five, two natural sub-groups emerge: pure-play fee-and-carry managers (BX, ARES, EQT, PGHN) and insurance-flywheel hybrids (KKR, APO).

Three takeaways from the peer set. Scale and value diverge in this industry: Blackstone is 5× PGHN by market cap but earns a lower EBITDA margin by 12 percentage points, because BX's mix carries more open-ended NAV-fee structures and a heavier private-wealth servicing cost base. EQT is the cleanest direct comp — same European pure-play structure, same thematic platform, same private-wealth angle — and trades at 26.0× EV/EBITDA versus PGHN's 16.0×, a 60% premium for stronger fundraising velocity, the pending Coller Capital combination, and a higher private-wealth share. APO and KKR are economically different animals: consolidated EBITDA margins (26% and ~4%) are not directly comparable because they include Athene/Global Atlantic insurance investment income; their fee-only "asset management" segments run closer to BX and PGHN, but the hybrid model itself is the differentiator.

Where The Company Wins

PGHN does four things measurably better than every public peer. None of them is "we are the biggest" — and that is the whole point of the franchise.

1. Highest EBITDA margin in the listed peer set, on a stable 20-year fee-rate band. Group EBITDA margin was 62.8% in FY2025 (USD 2,032m EBITDA on USD 3,233m revenue, per FY2025 results) and has held inside 62-65% for seven straight years. The reason is mix, not size. PGHN's management-fee margin (gross fees ÷ average AuM) has stayed inside a narrow 1.18-1.33% range every year from 2006 to 2025 despite waves of fee compression in public-market asset management — only EQT comes close on margin (52.5% group EBITDA), and EQT does it on a thematic-PE-heavy book that is more concentrated by strategy. Blackstone, the scale leader, runs at 50.5%; Ares at ~20% on a credit-heavy mix; Apollo at 26.4% on a consolidated basis distorted by Athene. Source: PGHN business tab; FY2025 income.json across peers.

2. Highest bespoke/evergreen share of AuM, which converts directly into pricing-power durability. PGHN reports 33% bespoke separate-account mandates + 37% evergreens = 67% non-commoditised AuM (CMD March 2026, p. 8). Bespoke mandates are committee-cycle decisions with consultant relationships and multi-year RFP processes — switching costs are measured in 18-24 month sales cycles, not basis points. Evergreens are the second moat: PGHN was the first manager to launch a PE 40-Act fund (US), the first to launch a PM ELTIF (Europe), and the first to launch a US PE DC CIT for retirement plans. The CMD 2026 deck notes "~30% semiliquid/evergreen" of AuM versus single-digit shares for most rivals. By contrast, BX and APO are catching up on retail evergreens but starting from large institutional drawdown books; EQT only crossed 26% wealth-share of fundraising in 2024-25 (per industry-research); KKR and ARES are still scaling.

3. Best-in-class ROE (54.8%), which is genuine economic returns x capital discipline. PGHN's ROE is multiples of BX (29.2%), APO (14.7%), ARES (13.5%), KKR (8.8%) and EQT (9.3%). Two-thirds of the difference is the asset-light fee-and-carry model with capex of USD 10m on USD 3,233m revenue in FY25; the remaining third is a ~95% dividend payout that keeps the equity base small. ROE this high in the absence of leverage, hedge-book gearing, or acquisition goodwill is unusual — it is the cleanest single number that proves the bespoke-architecture story is real, not story-telling. Source: business-claude tab; ratios.json across peers.

4. The most diversified asset-class platform among non-insurance peers. PGHN is the only listed pure-play that runs at meaningful scale across all five private-markets segments: PE 46%, credit 22%, infrastructure 19%, real estate 12%, plus royalties (the only listed peer with a sizeable royalties book). EQT lacks credit and royalties; ARES is credit-dominant (75%+); BX is RE/credit-led. The cross-asset reach is what enables the bespoke-mandate model — a single pension-fund client can give PGHN one ticket spanning four asset classes with bespoke pacing and bespoke fees, which neither pure-PE EQT nor credit-led ARES can match.

Where Competitors Are Better

Four areas where PGHN is genuinely behind, with the specific competitor that exposes the gap.

1. Distribution scale into private wealth — Blackstone is far ahead. BX raised USD 43bn from private wealth in 2025, +53% YoY, across BREIT, BCRED, BXPE, BXINFRA and BXPE-style vehicles (per industry-research and BX FY2025 10-K). PGHN does not break out absolute private-wealth fundraising by year, but its evergreen Master Fund is sub-USD 20bn AuM and its 2024-25 evergreen inflows (per CMD 2026) were a fraction of BX's pace. The implication is mix-shift risk: as private-wealth AuM dilutes the institutional-mandate base across the industry, the firms with bigger wealth-distribution rails (BX, APO via Apollo Wealth, eventually KKR via DC channels) capture disproportionately more of the next leg of growth. PGHN's three 2025 JV signings — Deutsche Bank for evergreen launch, PGIM for multi-asset, Generali for credit secondaries — are the right response, but they are partnerships, not owned distribution. Source: BX FY2025 10-K business section; industry-claude tab §3.

2. Insurance balance-sheet flywheel — APO and KKR have a structural fee-plus-spread advantage that PGHN cannot replicate. Apollo consolidates Athene and KKR consolidates Global Atlantic, two annuity insurers that produce permanent capital plus a spread-investment income stream. APO's consolidated revenue was USD 32.0bn in FY2025 versus PGHN's USD 3.2bn — most of the gap is investment income from Athene, not fee revenue, but the structure is what allows APO to underwrite below-market direct origination, retain inflows during fundraising droughts, and grow AuM through accretive insurance M&A. PGHN has explicitly chosen not to acquire an insurance carrier (CFO commentary, FY2024 results) and instead positions its co-investment book (USD 2.1bn alongside clients) as a skin-in-the-game model. That is a strategic choice with merits, but it means PGHN earns fees on a smaller permanent-capital pool than the hybrids do, and is more exposed to fundraising cycles.

3. Credit franchise depth — Apollo and Ares dominate direct lending. Apollo manages USD 749.2bn of credit AUM (10-K p. 14), of which USD 302.1bn is direct origination plus USD 282.7bn asset-backed finance. Ares' Credit Group manages USD 406.9bn AUM with USD 274.3bn in direct lending across US and Europe. PGHN's private-credit AuM is roughly USD 41bn (22% of USD-equivalent AuM at YE25, per CMD 2026). For LP clients building large multi-strategy private-credit allocations, PGHN is a participant rather than a destination — which limits its share of the fastest-growing segment of private markets (private credit grew ~21% CAGR 2020-25 versus PE ~9%). The 2025 Generali credit-secondaries JV is the right strategic answer, but it does not close the absolute scale gap with APO/ARES anywhere near term.

4. Fundraising velocity is materially behind US scale leaders. Ares reported USD 30bn of fundraising in Q1 2026 alone (Hedgeco, May 2026). Apollo crossed USD 1 trillion AuM in early 2026. BX added more than USD 100bn of net AuM in 2025 across all channels. PGHN guided FY2026 gross client demand at USD 26-32bn for the full year — meaning Ares' Q1 alone was roughly equal to PGHN's full-year ambition. Smaller absolute fundraising magnifies any single-client churn risk and slows AuM compounding. Q1 2026 PGHN fundraising came in at USD 8.3bn (annualised at upper end of guide), which is healthy on a relative basis but does not change the absolute scale gap.

These four gaps are correlated: smaller fundraising → smaller AuM growth → less leverage to drop incremental new-money fees onto a fixed cost base → harder to fund the marketing and seeding cost of new evergreen launches. The bull case requires the bespoke moat to widen faster than the scale gap closes against it.

Threat Map

The map below ranks the threats not by which competitor is biggest in absolute terms but by which one most directly compresses PGHN's specific fee or AuM base over the next 24 months.

The two threats that combine High severity + near-term horizon — private-wealth share capture and evergreen redemption stress — both run through the semiliquid retail-private-markets product line and both are the variables behind the March-April 2026 PGHN drawdown. The insurance-flywheel threat is structural and cannot be neutralised by execution: the industry's best competitive answer (build or buy an insurer) has been ruled out by PGHN management.

Moat Watchpoints

Five measurable signals an investor should watch each quarter to know whether PGHN's competitive position is improving or weakening. None of them are about Q-on-Q EPS noise; all are about the durable fee-and-mix engine.